Close

Bristol-Myers Squibb (BMY) Announces Strong Data from Yervoy Phase 3 vs. Placebo in Melanoma Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. LRCX
7. BIIB
8. CNMD
9. BSX
10. ASGN


Go back to Bristol-Myers Squibb (BMY) Announces Strong Data from Yervoy Phase 3 vs. Placebo in Melanoma Patients

Bristol-Myers Squibb (BMY) Shows Strength, Shares Up 1.8%

October 12, 2016 9:53 AM EDT

Bristol-Myers Squibb (NYSE: BMY) Shows Strength, Shares Up 1.8%

... More